Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#151 / 200 Total
ZENV - Zenvia Inc - Stock Price Chart
TickerZENV [NASD]
CompanyZenvia Inc
CountryBrazil
IndustrySoftware - Application
Market Cap174.04MEPS (ttm)-0.29
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S1.07EPS next 5Y-
P/B0.78EPS Q/Q79.63%
Dividend-Sales Q/Q31.60%
Insider Own96.66%Inst Own7.63%
Insider Trans0.00%Inst Trans-4.38%
Short Float2.27%EarningsApr 30/a
Analyst Recom3.00Target Price1.81
Avg Volume80.98K52W Range0.65 - 3.88
Today 09:00AM 3 Under-$10 Stocks Set for Monumental Gains by 2026 (InvestorPlace)
May-21-24 07:49AM Top Premarket Decliners (MT Newswires) -14.29%
07:39AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace)
May-15-24 01:53PM ZENV Stock Earnings: Zenvia Reported Results for Q4 2023 (InvestorPlace)
07:00AM Zenvia Files its Annual Report on Form 20-F for Fiscal Year 2023 (PR Newswire)
May-13-24 08:30PM ZENVIA Reports Q4 2023 and FY 2023 Results (PR Newswire)
May-03-24 07:00AM 3 Little-Known Stocks That Could Make You Rich by 2029 (InvestorPlace)
Apr-20-24 06:00AM Hidden Titans: 3 Stocks Ready to Outperform in the Next Earnings Season (InvestorPlace)
Apr-15-24 08:50AM ZENVIA sets agenda for fiscal fourth quarter and full year results (PR Newswire)
Apr-09-24 08:00AM Secret Millionaires: 3 Underpriced Stocks to Skyrocket Your Wealth (InvestorPlace)
NRSN - NeuroSense Therapeutics Ltd - Stock Price Chart
TickerNRSN [NASD]
CompanyNeuroSense Therapeutics Ltd
CountryIsrael
IndustryBiotechnology
Market Cap20.22MEPS (ttm)-0.85
P/E-EPS this Y12.05%
Forward P/E-EPS next Y16.44%
PEG-EPS past 5Y-7.06%
P/S-EPS next 5Y-
P/B-EPS Q/Q28.27%
Dividend-Sales Q/Q-
Insider Own28.41%Inst Own1.07%
Insider Trans0.00%Inst Trans-58.06%
Short Float0.17%EarningsApr 05/b
Analyst Recom1.00Target Price5.25
Avg Volume245.16K52W Range0.40 - 2.33
May-20-24 09:00AM NeuroSense Vice President of R&D Shiran Zimri, Ph.D. to Participate in the 3rd Annual ALS Drug Development Summit (PR Newswire)
May-14-24 09:05AM NeuroSense Partners with PhaseV to Optimize Upcoming ALS Phase 3 Trial Using Advanced Causal Machine Learning (PR Newswire)
May-07-24 08:45AM NeuroSense Announces New Positive Data Analysis from PARADIGM Clinical Trial Demonstrating Statistically Significant Slowing of Disease Progression in High-Risk ALS Patients (PR Newswire)
May-02-24 09:19AM NeuroSense Announces First Quarter 2024 Business Update (PR Newswire)
Apr-22-24 08:30AM NeuroSense and Genetika+ Initiate Precision Medicine Collaboration Beginning with Ongoing Phase 2 Clinical Trial in Alzheimer's Disease (PR Newswire)
Apr-18-24 08:30AM NeuroSense Presents Positive Data Validating Phase 2b Topline Readout During Emerging Science Presentation at the American Academy of Neurology Annual Meeting (PR Newswire) -5.00%
Apr-12-24 08:30AM NeuroSense to Present PARADIGM Data at the American Academy of Neurology Annual Meeting April 16, 2024 (PR Newswire)
Apr-10-24 07:16PM NeuroSense Announces Pricing of $4.5 Million Registered Direct Offering and Concurrent Private Placement (PR Newswire)
Apr-09-24 08:30AM NeuroSense Collaborates with Lonza to Identify Exosome-based Biomarkers, in order to Advance Neurodegenerative Disease Treatments and Diagnostics (PR Newswire)
Apr-05-24 08:52PM NRSN Stock Earnings: NeuroSense Therapeutics Beats EPS for Q4 2023 (InvestorPlace) -17.48%
AIMD - Ainos Inc - Stock Price Chart
TickerAIMD [NASD]
CompanyAinos Inc
CountryUSA
IndustryMedical Devices
Market Cap6.66MEPS (ttm)-3.16
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-3.59%
P/S73.96EPS next 5Y-
P/B0.29EPS Q/Q8.80%
Dividend-Sales Q/Q-57.84%
Insider Own54.44%Inst Own1.33%
Insider Trans0.00%Inst Trans-
Short Float3.43%Earnings-
Analyst Recom-Target Price-
Avg Volume1.43M52W Range0.79 - 6.10
May-15-24 08:00AM Ainos to Initiate Clinical Study of New Potential VELDONA-Based Animal Drug, Expanding VELDONA's Potential Market (ACCESSWIRE)
May-13-24 09:54PM AIMD Stock Earnings: Ainos Reported Results for Q1 2024 (InvestorPlace)
04:10PM Ainos Reports First Quarter 2024 Financial Results (ACCESSWIRE)
May-07-24 08:00AM Ainos Raises $9 Million in Growth Capital with Existing Shareholder (ACCESSWIRE)
Mar-08-24 04:20PM Ainos Reports Full Year 2023 Financial Results (ACCESSWIRE) +83.04%
07:58AM Why Is Ainos (AIMD) Stock Up 153% Today? (InvestorPlace)
Mar-04-24 08:22AM Why Is Ainos (AIMD) Stock Up 57% Today? (InvestorPlace) +35.24%
Feb-08-24 08:35AM Small-Cap Growth Virtual Investor Conference Presentations Now Available for Online Viewing (GlobeNewswire)
Feb-06-24 09:51AM Small-Cap Growth Virtual Investor Conference Agenda Announced for February 7th, 2024 (GlobeNewswire) -7.81%
Feb-05-24 09:00AM Ainos Submits Clinical Hold Complete Response to US FDA to Resolve the Deficiencies on Investigational New Drug Phase II Trial of its VELDONA Formulation Against Mild COVID-19 Symptoms (ACCESSWIRE)
BZFD - BuzzFeed Inc - Stock Price Chart
TickerBZFD [NASD]
CompanyBuzzFeed Inc
CountryUSA
IndustryInternet Content & Information
Market Cap113.99MEPS (ttm)-1.57
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.42EPS next 5Y47.50%
P/B1.38EPS Q/Q4.55%
Dividend-Sales Q/Q-33.35%
Insider Own62.82%Inst Own9.08%
Insider Trans-11.43%Inst Trans-
Short Float8.58%EarningsMay 13/a
Analyst Recom3.00Target Price4.00
Avg Volume1.63M52W Range0.64 - 4.56
May-22-24 02:52PM BuzzFeed stock surges after former presidential candidate Vivek Ramaswamy buys activist stake (Quartz) +20.40%
12:34PM Barnes & Noble Education (BNED) Stock Pops 73% in Second Day of Rally (InvestorPlace)
12:19PM GigaCloud (GCT) Stock Plunges on Grizzly Research Short Report (InvestorPlace)
12:11PM Vivek Ramaswamy Is Betting Big on BuzzFeed (BZFD) Stock (InvestorPlace)
10:41AM BuzzFeed stock soars after Vivek Ramaswamy acquires activist stake (Yahoo Finance)
09:42AM BuzzFeed Stock Jumps on News of Vivek Ramaswamy Stake (The Wall Street Journal)
May-17-24 09:00AM BuzzFeed Inc., Bullish About Future of the Company, Redefines Compensation Model to Drive Value Creation (Business Wire)
May-13-24 09:53PM BZFD Stock Earnings: BuzzFeed Misses Revenue for Q1 2024 (InvestorPlace)
04:37PM BuzzFeed, Inc. First Quarter 2024 Financial Results in Line With March Outlook (Business Wire)
01:59PM Stocks to Watch Monday: GameStop, AMC, Incyte, Kraft Heinz (The Wall Street Journal)
YQ - 17 Education & Technology Group Inc ADR - Stock Price Chart
TickerYQ [NASD]
Company17 Education & Technology Group Inc ADR
CountryChina
IndustryEducation & Training Services
Market Cap19.08MEPS (ttm)-4.82
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y19.98%
P/S0.80EPS next 5Y6.61%
P/B0.27EPS Q/Q-6.39%
Dividend-Sales Q/Q17.83%
Insider Own3.52%Inst Own0.64%
Insider Trans0.00%Inst Trans-25.11%
Short Float0.79%EarningsDec 06/a
Analyst Recom4.00Target Price8.95
Avg Volume9.65K52W Range1.41 - 5.75
Apr-25-24 07:30AM 17 Education & Technology Group Inc. Files Its Annual Report on Form 20-F (GlobeNewswire)
Mar-21-24 11:51AM Q4 2023 17 Education & Technology Group Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-20-24 09:52PM YQ Stock Earnings: 17 Education & Technology Reported Results for Q4 2023 (InvestorPlace)
05:00PM 17 Education & Technology Group Inc. Announces Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results (GlobeNewswire)
Mar-15-24 07:00AM 17 Education & Technology Group Inc. to Report Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results on March 20, 2024 (GlobeNewswire)
Jan-05-24 05:24AM 17EdTech Has Regained Compliance with Nasdaq's Minimum Bid Price Requirement (GlobeNewswire) +19.89%
Dec-20-23 10:52AM YQ Stock Earnings: 17 Education & Technology Reported Results for Q1 2023 (InvestorPlace) +7.95%
Dec-12-23 06:00PM 17 Education & Technology Group Inc. Announces Plan to Implement ADS Ratio Change (GlobeNewswire)
Dec-06-23 05:00PM 17 Education & Technology Group Inc. Announces Third Quarter 2023 Unaudited Financial Results (GlobeNewswire)
Nov-30-23 05:00AM 17 Education & Technology Group Inc. to Report Third Quarter 2023 Unaudited Financial Results on December 6, 2023 (GlobeNewswire)
AKTX - Akari Therapeutics Plc ADR - Stock Price Chart
TickerAKTX [NASD]
CompanyAkari Therapeutics Plc ADR
CountryUSA
IndustryBiotechnology
Market Cap15.44MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q100.00%
Dividend-Sales Q/Q-
Insider Own0.40%Inst Own2.28%
Insider Trans0.00%Inst Trans-
Short Float0.16%EarningsMay 16/b
Analyst Recom1.00Target Price80.00
Avg Volume19.15K52W Range1.08 - 5.50
May-16-24 08:00AM Akari Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights (GlobeNewswire)
May-01-24 08:01AM Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics (GlobeNewswire) +10.39%
08:00AM Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merger Entity (GlobeNewswire)
Apr-15-24 08:00AM Akari Therapeutics to Present PAS-Nomacopan Pre-Clinical Electroretinography (ERG) Data at ARVO 2024 (GlobeNewswire)
Apr-01-24 06:30AM Akari Therapeutics Reports Full-Year 2023 Financial Results and Recent Highlights (GlobeNewswire) -19.03%
Mar-08-24 04:38PM Kuehn Law Encourages VIVK, HES, SDPI, and AKTX Investors to Contact Law Firm (GlobeNewswire)
Mar-05-24 08:00AM Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expanded Pipeline That Features a Novel Antibody Drug Conjugate (ADC) Toolkit (GlobeNewswire)
Jan-02-24 08:00AM Akari Therapeutics Announces Existing Investors Support the Company Through a $2 Million Private Placement Financing (GlobeNewswire) -7.16%
Dec-14-23 08:00AM Akari Therapeutics to Present at Biotech Showcase 2024 (GlobeNewswire) +5.84%
Dec-01-23 08:00AM Akari Therapeutics Appoints Experienced Life Sciences Entrepreneur Samir R. Patel, M.D. to Board of Directors (GlobeNewswire) +9.49%
CVRX - CVRx Inc - Stock Price Chart
TickerCVRX [NASD, RUT]
CompanyCVRx Inc
CountryUSA
IndustryMedical Devices
Market Cap160.92MEPS (ttm)-2.48
P/E-EPS this Y-30.65%
Forward P/E-EPS next Y25.51%
PEG-EPS past 5Y-27.17%
P/S3.82EPS next 5Y-
P/B2.43EPS Q/Q-90.12%
Dividend-Sales Q/Q34.98%
Insider Own49.34%Inst Own32.11%
Insider Trans-0.06%Inst Trans-5.10%
Short Float8.02%EarningsApr 30/a
Analyst Recom1.67Target Price16.60
Avg Volume217.03K52W Range7.06 - 33.13
May-22-24 08:30AM CVRx to Present at the William Blair 44th Annual Growth Stock Conference (GlobeNewswire)
May-16-24 07:30AM CVRx Announces Key Senior Leadership Team Hires (GlobeNewswire)
May-01-24 10:45AM CVRx, Inc. (NASDAQ:CVRX) Q1 2024 Earnings Call Transcript (Insider Monkey) -34.75%
08:39AM Why Is CVRx (CVRX) Stock Down 32% Today? (InvestorPlace)
07:42AM Q1 2024 CVRx Inc Earnings Call (Thomson Reuters StreetEvents)
07:31AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace)
Apr-30-24 08:56PM CVRX Stock Earnings: CVRx Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
05:44PM CVRx Inc (CVRX) Reports Q1 2024 Results: Revenue Growth Amid Challenges (GuruFocus.com)
04:34PM CVRx: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM CVRx Reports First Quarter 2024 Financial and Operating Results (GlobeNewswire)
PHVS - Pharvaris NV - Stock Price Chart
TickerPHVS [NASD]
CompanyPharvaris NV
CountryNetherlands
IndustryBiotechnology
Market Cap1.09BEPS (ttm)-2.71
P/E-EPS this Y12.49%
Forward P/E-EPS next Y-11.38%
PEG-EPS past 5Y-28.27%
P/S-EPS next 5Y20.59%
P/B2.49EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own64.76%Inst Own30.92%
Insider Trans0.00%Inst Trans-0.09%
Short Float0.66%EarningsMay 08/a
Analyst Recom1.43Target Price32.82
Avg Volume74.81K52W Range8.20 - 33.00
May-13-24 06:50AM Pharvaris to Present Clinical and Nonclinical Data at Upcoming Congresses (GlobeNewswire)
May-08-24 11:55PM PHVS Stock Earnings: Pharvaris Misses EPS for Q1 2024 (InvestorPlace) -7.82%
04:10PM Pharvaris Reports First Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
Apr-10-24 09:52PM PHVS Stock Earnings: Pharvaris Misses EPS for Q4 2023 (InvestorPlace)
04:10PM Pharvaris Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update (GlobeNewswire)
04:08PM Pharvaris Appoints David Nassif, J.D., as Chief Financial Officer (GlobeNewswire)
Apr-04-24 06:50AM Pharvaris to Present Deucrictibant Clinical Data at the CIIC Spring 2024 Conference (GlobeNewswire)
Mar-18-24 06:50AM Pharvaris Announces Phase 3 Clinical Study Design for Recently Initiated RAPIDe-3 Study, and Presents Quality-of-Life Improvement and Caregiver Behavior Data at Two Recent HAE Congresses (GlobeNewswire) +6.34%
Mar-06-24 06:50AM Pharvaris to Present Deucrictibant Clinical Data at Upcoming Congresses (GlobeNewswire) +5.86%
Mar-05-24 06:50AM Pharvaris to Participate in the Leerink Global Biopharma Conference 2024 (GlobeNewswire)
ISSC - Innovative Solutions And Support Inc - Stock Price Chart
TickerISSC [NASD]
CompanyInnovative Solutions And Support Inc
CountryUSA
IndustryAerospace & Defense
Market Cap111.76MEPS (ttm)0.36
P/E17.67EPS this Y8.57%
Forward P/E11.41EPS next Y47.37%
PEG0.88EPS past 5Y-
P/S2.73EPS next 5Y20.00%
P/B2.70EPS Q/Q-5.60%
Dividend-Sales Q/Q46.31%
Insider Own39.17%Inst Own30.36%
Insider Trans0.29%Inst Trans-7.42%
Short Float0.19%EarningsMay 13/b
Analyst Recom1.00Target Price9.70
Avg Volume40.24K52W Range4.91 - 9.00
May-17-24 11:19AM Innovative Solutions & Support, Inc. to Participate in the Singular Research Spring Select Conference (Business Wire)
May-16-24 04:00PM Innovative Solutions & Support, Inc. Appoint New Board Member (Business Wire)
May-14-24 03:01AM Innovative Solutions and Support Inc (ISSC) (Q2 2024) Earnings Call Transcript Highlights: ... (GuruFocus.com)
12:56AM Q2 2024 Innovative Solutions and Support Inc Earnings Call (Thomson Reuters StreetEvents)
May-13-24 12:52PM ISSC Stock Earnings: Innovative Solns Reported Results for Q2 2024 (InvestorPlace) -11.68%
08:30AM Innovative Solutions & Support, Inc. Announces Second Quarter Fiscal 2024 Financial Results (Business Wire)
May-07-24 09:15AM Sidoti Events, LLC's Virtual May Micro-Cap Conference (ACCESSWIRE)
May-02-24 04:15PM Innovative Solutions & Support, Inc. to Participate in the Sidoti Virtual MicroCap Investor Conference (Business Wire)
May-01-24 04:00PM Innovative Solutions & Support, Inc. Announces Date of Conference Call and Webcast to Discuss Second Quarter Fiscal 2024 Financial Results (Business Wire)
Mar-21-24 04:00PM Innovative Solutions & Support, Inc. Announces New Chief Financial Officer (Business Wire)
CGTX - Cognition Therapeutics Inc - Stock Price Chart
TickerCGTX [NASD]
CompanyCognition Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap102.15MEPS (ttm)-0.92
P/E-EPS this Y-14.25%
Forward P/E-EPS next Y-22.82%
PEG-EPS past 5Y-21.09%
P/S-EPS next 5Y-
P/B3.53EPS Q/Q-27.91%
Dividend-Sales Q/Q-
Insider Own22.67%Inst Own17.90%
Insider Trans0.06%Inst Trans-0.77%
Short Float0.40%EarningsMay 07/b
Analyst Recom1.00Target Price6.67
Avg Volume166.02K52W Range0.90 - 3.49
May-21-24 07:30AM Cognition Therapeutics Releases New Episode of Conversations Podcast: Protecting the Synapse from Amyloid Toxicity in Alzheimer's Disease (GlobeNewswire) +8.10%
May-07-24 01:53PM CGTX Stock Earnings: Cognition Therapeutics Beats EPS for Q1 2024 (InvestorPlace)
07:30AM Cognition Therapeutics Reports Financial Results for the First Quarter 2024 and Provides Business Update (GlobeNewswire)
Apr-29-24 07:30AM Cognition Therapeutics Completes Enrollment in Phase 2 SHIMMER Study of CT1812 in Mild-to-Moderate Dementia with Lewy Bodies (GlobeNewswire)
Apr-22-24 07:30AM Cognition Therapeutics KOL Event Provided Platform for Valuable Discussion of Current Therapeutic Options and Need for Additional Options to Treat Alzheimer's Disease (GlobeNewswire)
Apr-02-24 07:30AM Cognition Therapeutics to Present at the Needham Virtual Healthcare Conference (GlobeNewswire)
Apr-01-24 07:30AM Cognition Therapeutics to host Virtual KOL Event on the Evolving Landscape in Alzheimer's Disease on April 12, 2024 (GlobeNewswire)
Mar-27-24 09:31AM Cognition Therapeutics, Inc. (NASDAQ:CGTX) Q4 2023 Earnings Call Transcript (Insider Monkey)
01:13AM Q4 2023 Cognition Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-26-24 11:53AM CGTX Stock Earnings: Cognition Therapeutics Beats EPS for Q4 2023 (InvestorPlace)
1⋯1011121314151617181920
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.